- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Biometry.
Displaying page 1 of 1.
| EudraCT Number: 2011-005979-16 | Sponsor Protocol Number: PrOvAS001 | Start Date*: 2013-04-29 |
| Sponsor Name:Instituto de Investigación Sanitaria La Fe | ||
| Full Title: PREECLAMPSIA OF PREVENTION IN PATIENTS THROUGH ovodonation aspirin in early gestation | ||
| Medical condition: PREECLAMPSIA | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-004108-23 | Sponsor Protocol Number: 17097AB-AS | Start Date*: 2018-10-09 |
| Sponsor Name:Belfast Health and Social Care Trust | ||
| Full Title: Low-dose atropine eye drops to reduce progression of myopia in children: a multi-centre placebo controlled randomised trial in the United Kingdom (CHAMP UK) | ||
| Medical condition: Myopia | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-003976-42 | Sponsor Protocol Number: OT_101_001 | Start Date*: Information not available in EudraCT |
| Sponsor Name:Ocumension (Hong Kong) Limited | ||
| Full Title: A phase III, randomized, double-masked, placebo controlled, parallel-group, multicenter study of the safety and efficacy of OT-101 (Atropine 0.01%) in treating the progression of myopia in pediatri... | ||
| Medical condition: myopia | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) SK (Trial now transitioned) IE (Trial now transitioned) HU (Trial now transitioned) ES (Ongoing) PL (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-003054-16 | Sponsor Protocol Number: DDZ-BOND-2017 | Start Date*: 2018-07-27 | |||||||||||
| Sponsor Name:Wörwag Pharma GmbH & co. KG | |||||||||||||
| Full Title: Randomized double-blind, placebo-controlled parallel group study over 12 months to assess the effects of treatment with benfotiamine on morphometric, neurophysiological, and clinical measures in ty... | |||||||||||||
| Medical condition: diabetic polyneuropathy | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2020-002046-16 | Sponsor Protocol Number: MARS_2020 | Start Date*: 2020-11-04 |
| Sponsor Name:Fakultní nemocnice Brno | ||
| Full Title: A Randomised, double-blinded, placebo-controlled, multicenter study of efficacy, safety and side effects of highly diluted atropine collyrium in slowing the progression of myopia (shortsightedness)... | ||
| Medical condition: Myopia in children | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: CZ (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-001286-16 | Sponsor Protocol Number: APP-study | Start Date*: 2018-11-05 | |||||||||||
| Sponsor Name:Rigshospitalet | |||||||||||||
| Full Title: Low-dose Atropine for the Prevention of Childhood Myopia Progression in Danish Children (APP-study) | |||||||||||||
| Medical condition: Childhood myopia | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2019-002461-35 | Sponsor Protocol Number: PREBOTPilot | Start Date*: 2019-12-06 | |||||||||||
| Sponsor Name:Ruprecht-Karls-University Heidelberg Medical Faculty represented by Universitätsklinikum Heidelberg and its acting Comm | |||||||||||||
| Full Title: Monocenter, randomized, controlled, open-label, phase-II clinical trial of PREoperative endoscopic injection of BOTulinum toxin in the sphincter of Oddi to reduce postoperative pancreatic fistula a... | |||||||||||||
| Medical condition: Elective distal pancreatectomy for any underlying disease | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2010-021662-30 | Sponsor Protocol Number: CRFB002F2301 | Start Date*: 2010-11-05 | |||||||||||||||||||||
| Sponsor Name:Novartis Pharma Services AG | |||||||||||||||||||||||
| Full Title: A 12 month, phase III, randomized, double-masked, multi-center, active-controlled study to evaluate the efficacy and safety of two different dosing regimens of 0.5 mg ranibizumab vs. verteporfin PD... | |||||||||||||||||||||||
| Medical condition: visual impairment due to choroidal neovascularization secondary to pathologic myopia | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: PT (Completed) LV (Completed) HU (Completed) LT (Completed) FR (Completed) ES (Completed) IT (Completed) AT (Completed) SK (Completed) DE (Completed) GB (Completed) | |||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
